Improved Targeting and Safety of Doxorubicin through a Novel Albumin Binding Prodrug Approach-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improved Targeting and Safety of Doxorubicin through a Novel Albumin Binding Prodrug Approach

Published:2023-12-21 Issue:1 Volume:9 Page:977-987
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Liu Yang¹^ORCID,Corrales-Guerrero Sergio²,Kuo Jimmy C.¹,Robb Ryan³,Nagy Gregory²,Cui Tiantian⁴,Lee Robert J.¹^ORCID,Williams Terence M.⁴^ORCID

Affiliation:

1. Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, Ohio 43210-1132, United States

2. Biomedical Sciences Graduate Program, The Ohio State University, Columbus, Ohio 43210-1132, United States

3. University of North Carolina, Chapel Hill, North Carolina 27514-3916, United States

4. Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California 91010, United States

Funder

National Cancer Institute

Ohio State University

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c07163

Reference58 articles.

1. Albumin as a versatile platform for drug half-life extension

2. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells

3. Editorial (Thematic Issue: HSA-Based Drug Development and Drug Delivery Systems)

4. Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?

5. Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biodistribution and preclinical safety profile of legubicin: A novel conjugate of doxorubicin and a legumain‐cleavable peptide linker;Journal of Applied Toxicology;2024-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3